Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol

INTRODUCTION: Enterococcus spp is responsible for 8%–15% of total bacteraemias with an associated global mortality around 23%–30%. Regarding the clinical management of enterococcal bacteraemia, the evidence on the duration of antibiotic treatment is scarce and the studies do not discriminate between...

Descripción completa

Detalles Bibliográficos
Autores principales: Maldonado, Natalia, Rosso-Fernández, Clara M, Portillo-Calderón, Inés, Borreguero Borreguero, Irene, Tristán-Clavijo, Enriqueta, Palacios-Baena, Zaira R, Salamanca, Elena, Fernández-Cuenca, Felipe, De-Cueto, Marina, Stolz-Larrieu, Emilio, Rodriguez-Baño, Jesús, López-Cortés, Luis Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496718/
https://www.ncbi.nlm.nih.gov/pubmed/37673453
http://dx.doi.org/10.1136/bmjopen-2023-075699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496718/
https://www.ncbi.nlm.nih.gov/pubmed/37673453
http://dx.doi.org/10.1136/bmjopen-2023-075699

Ejemplares similares